Ligand validation:5AHY

RET: RETINAL

RET is a Ligand Of Interest in 5AHY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AHY_RET_A_900	69%	40%	0.128	0.942	0.65	1.72	-	5	0	0	100%	0.9524
5AHZ_RET_A_900	75%	38%	0.125	0.958	0.72	1.77	-	8	0	0	100%	0.9524
5G36_RET_A_1262	68%	39%	0.138	0.95	0.74	1.71	-	6	0	0	100%	0.9524
7XJE_RET_A_301	99%	7%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
7XJC_RET_A_301	97%	11%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752
7XJD_RET_A_301	97%	11%	0.06	0.972	1.93	2.42	2	14	0	0	100%	0.9524
5ZIN_RET_A_250	96%	7%	0.054	0.964	2.81	2.16	4	10	0	0	100%	0.9524
6TK7_RET_A_301	96%	62%	0.059	0.967	0.85	0.59	1	-	1	0	100%	0.9524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.